Font Size: a A A
Keyword [Percutaneous transluminal coronary]
Result: 41 - 60 | Page: 3 of 3
41. Doppler Tissue Imaging With 16-slice Ct Coronary Heart Disease Diagnostic Value
42. Effect Of Co-transfection Of VEGF And PCNA-ASODN On Restenosis In Rabbits After Percutaneous Transluminal Coronary Angioplasty
43. Relationship Between BNP Levels And Coronary Severity In Patients In Patients With Acute Coronary Syndrome After PCI
44. The Effect Of GP Inhibitors And α-adrenergic Blocking Agents On The No-reflow Phenomenon During PCI
45. Evaluation Of Cardiac Function After Percutaneous Coronary Intervention Of Chronic Total Occlusion Of Coronary Artery(CTO)
46. Clinical Significance Of The QT Dispersion In Patients With Coronary Syndromre And The QT Dispersion Changes Of After PCI
47. Effect Of Amlodipine On In-stent Restenosis After Percutaneous Transluminal Coronary Intervention And Research Of Its Correlations With Adiponectin
48. The Assessment Of The Antiplatelet Therapy For The High-risk CHD Patients With Clopidogrel Low-reactionunder The Assistance Of TEG
49. The Study On The Relationship Between Fragmented QRS And Coronary Disease
50. Inhibitory Effects Of Icarisid â…¡ On Intimal Hyperplasia In Rat Carotid Arteries Induced By Balloon Injury
51. Association Of Neutrophil To Lymphocyte Ratio With The New Atrial Fibrillation After Percutaneous Transluminal Coronary Intervention Of Non-ST-segment Elevation Myocardial Infarction
52. The Use Of Combined Thrombolysis And Antithrombotic Agents After Coronary Intervention For Thrombus Aspiration In Interventional Treatment Of STEMI Patients With High Thrombus Burden And Its Short-term Efficacy
53. The Clinical Research Of The Acute Gout Attacks After The Coronary Angiography And Percutaneous Transluminal Coronary Intervention In The Patients With Coronary Heart Disease
54. The Long-term Prognostic Influence Of Drug Therapy And Interventional Therapy To Acute Non-ST Segment Elevation Acute Myocardial Infarction
55. Study Of Drug Eluting Stent And Angioplasty For The Treatment Of Coronary Heart Disease In-stent Restenosis
56. Efficacy Of Drug-Coated Balloon For De Novo Small Vessel Lesion Of Coronary Artery
57. Restenotic outcomes and medical care costs following percutaneous transluminal coronary angioplasty with and without stent
58. A Retrospective Study Of Drug-Coated Balloon In The Treatment Of Left Main Bifurcation Lesions
59. Application Of Drug-coated Balloon In Coronary Artery Disease In De Novo
60. Effectiveness And Safety Of Different Strategies In The Management Of Coronary Stent Restenosis
  <<First  <Prev  Next>  Last>>  Jump to